Market open
$
52.88
Change
-1.56 -2.87%
Volume
Volume 2.90m
Jan 27, 2021, 10:38 a.m.
Real time quotes
Previous close
$ 54.44
$ 52.88
Change
-1.56 -2.87%
Day low
Day high
$52.79
$53.43

52 week low
52 week high
$36.15
$64.94

Market cap
$143.44B
Average volume
11.94M
P/E ratio
55.43
Rev. per Employee
$346,812
EPS
0.96
Dividend
0.45
Div yield
2.58%
Ex dividend date
8/13/20
MarketWatch News on AZN
-
As Governments Scramble for Vaccine Doses, More Supplies Seem Imminent
- Josh Nathan-Kazis
-
Tensions Rise in Europe on AstraZeneca Vaccine Woes
- Pierre Briançon
-
Here’s what the robot fund that’s beating the S&P 500 is investing in now
- Barbara Kollmeyer
-
EU puts pressure on AstraZeneca over vaccine delays
- Associated Press
-
Hungary Approves Russia’s Covid-19 Vaccine
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Analysts’ Recommendations for Valeant in June
- MarketRealist.com
-
Barclays Downgrades Pfizer Stock and Cuts Price Target
- MarketRealist.com
-
Benzinga's Top Upgrades, Downgrades For March 19, 2018
- Benzinga.com
Other News on AZN
-
Stocks Decline, With Tech Earnings in Focus
- Will Horner
-
Covid-19 Vaccines and How They Work
- Taylor Umlauf
-
AstraZeneca is taking part in EU meeting – company spokesman
- Seeking Alpha
-
My 5 Top Investment Trends And Trading Ideas For 2021
- Seeking Alpha
-
Why Moderna Stock Faces a Tough Slog Ahead
- InvestorPlace.com
-
Israel’s Covid-19 Vaccinations Hold Lessons for U.S.
- Felicia Schwartz
-
Vaccine Roundup: Merck Wipes Out (And More)
- Seeking Alpha
-
Workers Producing the Vaccine Need Vaccination
- Robert Kramer
-
Nasdaq, S&P 500 Finish at Records
- Anna Hirtenstein
-
The New Covid-19 Strain in South Africa: What We Know
- Gabriele Steinhauser
-
Vaccine Delays Damp Prospect of Normal Summer in Europe
- Noemie Bisserbe
-
Merck Scraps Covid Vaccine Candidates
- Jared S. Hopkins
- Loading more headlines...
Press Releases on AZN
-
Adult Vaccines Market to Witness Huge Growth by 2026 | AstraZeneca, Merck, Pfizer, Sanofi Pasteur
- Market Insight Reports
-
Which COVID-19 Stocks are In-Play Now - AZN, JNJ, MRNA
- Baystreet.ca
-
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against AstraZeneca plc
- BusinessWire - BZX
-
Blood Cancer Drugs Market to see Huge Growth by 2025 | Amgen, AbbVie, Celgene, Novartis
- Market Insight Reports
-
Merck to Stop Work on COVID Vaccines
- Baystreet.ca
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com